Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polestar Technologies is a recognized leader in optical sensing technologies, providing specialized monitoring solutions for the biopharmaceutical, medical, and industrial sectors. Founded in 1993, the company develops and manufactures high-precision sensors for measuring critical parameters such as pH, dissolved oxygen, and carbon dioxide in both conventional and single-use bioreactors. Their proprietary technology, including the integrated Disposable Optical Transducer (iDOT™), enables non-invasive, real-time monitoring that is essential for optimizing bioprocessing and drug development. Beyond biopharma, Polestar serves government and environmental clients with advanced sensing applications for homeland security and water quality. The company is headquartered in Needham Heights, Massachusetts, and continues to innovate in the field of rugged, maintenance-free optical sensing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polestar.